js6666金沙app-js6666金沙登录入口-欢迎您

Parainfluenza Virus 5 Expressing the G Protein of Rabies Virus Protects Mice after Rabies Virus Infection

Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection

Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5–based COVID-19 vaccine

Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China

Research progress and challenges to coronavirus vaccine development

Immunogenicity of Novel Mumps Vaccine Candidates Generated by Genetic Modification

A novel rabies vaccine based on a recombinant parainfluenza virus expressing rabies virus glycoprotein.

Zhenhai Chen, Ming Zhou, Xiudan Gao, Guoqing Zhang, Guiping Ren, Clement W. Gnanadurai, Zhen F. Fu, Biao He.

Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice

Zhenhai Chen, Tuhina Gupta, Pei Xua, Shannon Phan, Adrian Pickar , Wilson Yau, Russell K. Karls , Frederick D.Quinn, ...